11 articles for V Dal Piaz
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Further studies on 2-arylacetamide pyridazin-3(2H)-ones: design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists.

Universita Degli Studi Di Firenze
Pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as selective human A(1) adenosine receptor ligands.

Dipartimento Di Scienze Farmaceutiche
Further studies on arylpiperazinyl alkyl pyridazinones: discovery of an exceptionally potent, orally active, antinociceptive agent in thermally induced pain.

Dipartimento Di Scienze Farmaceutiche
6-methyl-2,4-disubstituted pyridazin-3(2H)-ones: a novel class of small-molecule agonists for formyl peptide receptors.

Universita Degli Studi Di Firenze
4-Amino-5-vinyl-3(2H)-pyridazinones and analogues as potent antinociceptive agents: Synthesis, SARs, and preliminary studies on the mechanism of action.

Dipartimento Di Scienze Farmaceutiche
Arylpiperazinylalkylpyridazinones and analogues as potent and orally active antinociceptive agents: synthesis and studies on mechanism of action.

Dipartimento Di Scienze Farmaceutiche
Novel pyrazolopyrimidopyridazinones with potent and selective phosphodiesterase 5 (PDE5) inhibitory activity as potential agents for treatment of erectile dysfunction.

Università
New pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as potent and selective PDE5 inhibitors.

RhôNe-Poulenc Rorer
Isoxazolo-[3,4-d]-pyridazin-7-(6H)-one as a potential substrate for new aldose reductase inhibitors.

Dipartimento Di Scienze Farmaceutiche
Functionalized pyrazoles and pyrazolo[3,4-d]pyridazinones: Synthesis and evaluation of their phosphodiesterase 4 inhibitory activity.

Universita Degli Studi Di Firenze
Novel heterocyclic-fused pyridazinones as potent and selective phosphodiesterase IV inhibitors.

Dipartimento Di Scienze Farmaceutiche, Firenze, Italy.